Answer
Imunovir (inosine acedoben dimepranol) should be avoided when pregnancy is suspected or confirmed and should not be administered during pregnancy or breastfeeding unless the physician decides benefits outweigh potential risk; controlled human foetal-risk trials are unavailable and excretion in human milk is unknown.
Sources for this answer
- Imunovir 500mg TabletsKora Healthcare · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 5Document updated
Sources checked